CD4 Therapeutics GmbH is a cutting-edge biopharmaceutical company founded in 2024 by a team of seasoned industry experts with over 30 years of experience in drug development, clinical research and successfully scaling biotech ventures. Our company is driven by the vision to transform patient care by developing groundbreaking therapies that address significant unmet medical needs in autoimmune and inflammatory diseases.